BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Introgen Therapeutics, Inc. 

301 Congress Avenue, Suite 1850

Austin  Texas  78701  U.S.A.
Phone: 512-320-5010 Fax: 512-320-4166


SEARCH JOBS


Industry
Biotechnology

Segment
Gene Therapy





 Company News
Introgen Therapeutics, Inc. (INGN) Announces Resignation of David G. Nance from Board of Directors 3/12/2009 9:21:26 AM    More...
Introgen Therapeutics, Inc. (INGN) Common Stock to be Delisted from the Nasdaq Stock Market 12/8/2008 10:58:17 AM    More...
Introgen Therapeutics, Inc. (INGN) Restructures Operations to Focus on Revenue-Generating Manufacturing Capabilities; Reduces Staff 12/1/2008 7:12:04 AM    More...
Introgen Therapeutics, Inc. (INGN) Announces the Transfer of its Listing of Common Stock from the Nasdaq Global Market to the Nasdaq Capital Market 11/19/2008 9:07:56 AM    More...
Introgen Therapeutics, Inc. (INGN) Hires An Adviser To Pursue Strategic Options, Including A Possible Sale 11/12/2008 7:10:59 AM    More...
Introgen Therapeutics, Inc. (INGN) Reports Third Quarter 2008 Financial Results 11/11/2008 9:45:39 AM    More...
Introgen Therapeutics, Inc. (INGN) Receives Notification From NASDAQ 10/6/2008 10:49:46 AM    More...
Introgen Therapeutics, Inc. (INGN) Receives Staff Determination Letter from Nasdaq Global Market 9/8/2008 9:13:06 AM    More...
Introgen Therapeutics, Inc. (INGN) Sell-Off Continues 9/4/2008 11:25:03 AM    More...
Introgen Therapeutics, Inc. (INGN) Receives Notice ADVEXIN(R) U.S. BLA Not Sufficiently Complete to File 9/2/2008 6:37:25 AM    More...
12345678910...

//-->